Influence of nitric oxide on vascular, metabolic, and contractile responses to dobutamine in in situ canine hearts

Anesthesia and Analgesia

Volumn 87, Issue 5, 1998, Pages 994-1001

  Crystal, George J ^a,b   Zhou, Xiping ^a,b   Gurevicius, Juozas ^a,b   Salem, M Ramez ^a,b  

^a ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; GLYCERYL TRINITRATE; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; DOG; DOSE RESPONSE; FEMALE; HEART MUSCLE OXYGEN CONSUMPTION; HEMODYNAMICS; INTRACORONARY INFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL;

ANIMALS; BLOOD PRESSURE; CARDIOTONIC AGENTS; CORONARY CIRCULATION; DOBUTAMINE; DOGS; ENZYME INHIBITORS; EXTRACORPOREAL CIRCULATION; FEMALE; HEART RATE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN CONSUMPTION; VASODILATOR AGENTS;

EID: 0031782831     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199811000-00003     Document Type: Article

References (24)

1. Bassenge E, Busse R. Endothelial modulation of coronary tone. Prog Cardiovasc Dis 1988;30:349-80.
2. Kaneko H, Endo T, Kiuchi K, Hayakawa H. Inhibition of nitric oxide synthesis reduces coronary blood flow response but does not increase cardiac contractile response to β-adrenergic simulation in normal dogs. J Cardiovasc Pharmacol 1996;27:247-54.
3. Parent R, Al-Obaidi M, Lavallée M. Nitric oxide formation contributes to β-adrenergic dilation of resistance coronary vessels in conscious dogs. Circ Res 1993;73:241-51.
4. Crystal GJ, Rock MH, Kim S-J, Salem MR. Effect of intracoronary infusions of amrinone and dobutamine on segment shortening, blood flow, and oxygen consumption in in situ canine hearts. Anesth Analg 1994;79:1066-74.
5. Crystal GJ, Gurevicius J. Nitric oxide does not modulate myocardial contractility acutely in in situ canine hearts. Am J Physiol 1996;270:H1568-51.
6. Balligand J-L, Kelly RA, Marsden PA, et al. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 1993;90:347-51.
7. Feigl EO: Coronary physiology. Physiol Rev 1983;63:1-205.
8. Glantz SA, Slinker BK. Primer of applied regression and analysis of variance. New York: McGraw-Hill, 1990.
9. Altman JD, Kinn J, Duncker DJ, Bache RJ. Effect of inhibition of nitric oxide formation on coronary blood flow in the dog. Cardiovasc Res 1994;28:119-24.
10. Matsunaga T, Okumura K, Tsunoda R, et al. Role of adenosine in regulation of coronary flow in dogs with inhibited synthesis of endothelium-derived nitric oxide. Am J Physiol 1996;270: H427-34.
11. Gray DW, Marshall I. Novel signal transduction pathway mediating endothelium dependent β-adrenoreceptor vasorelaxing in rat thoracic aorta. Br J Pharmacol 1992;107:684-90.
12. Young AA, Vatner SF. Regulation of large coronary arteries. Circ Res 1986;59:579-96.
13. Ghaleh B, Béa M-L, Dubois-Randé J-L, et al. Endothelial modulation of β-adrenergic dilation of large coronary arteries in conscious dogs. Circulation 1995;92:2627-35.
14. Saeki A, Recchia FA, Senzaki H, Kass DA. Minimal role of nitric oxide in basal coronary flow regulation and cardiac energetics of blood-perfused isolated canine heart. J Physiol (London) 1996;491.2:455-63.
15. Vemer IR. Direct-acting vasodilators. In: Enderby GEH, ed. Hypotensive anaesthesia. Edinburgh, UK: Churchill Livingstone, 1985:138-53.
16. Henning RJ, Khalil IR, Levy MN. Vagal stimulation attenuates sympathetic enhancement of left ventricular function. Am J Physiol 1990;258:H1470-5.
17. Hare JM, Keaney JF Jr, Balligand J-L, et al. Role of nitric oxide in parasympathetic modulation of β-adrenergic myocardial contractility in normal dogs. J Clin Invest 1995;95:360-6.
18. Landsberg JS, Parker JD, Gauthier DF, Colucci WS. Effects of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility. Circulation 1994;89:164-8.
19. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-41.
20. DeBelder AJ, Radomski M, Why HJ, et al. Nitric oxide synthase activities in human myocardium. Lancet 1993;341:84-5.
21. DeBelder AJ, Radomski M, Why HJ, et al. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvular heart disease. Br Heart J 1995; 74:426-30.
22. Haywood GA, Tsao PS, von der Leyen HE, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996;93:1087-94.
23. Hare JM, Givertz MM, Creager MA, Colucci WS. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of β-adrenergic inotropic responsiveness. Circulation 1998;97:161-6.
24. Xie Y-W, Shen W, Zhao G, et al. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro: implications for the development of heart failure. Circ Res 1996;79:381-7.